JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB254530

Anti-CD44 antibody [Hermes-3]

  • BOND RX™ Validated
  • KO Validated
  • Recombinant
  • Lab Essentials
  • What is this?

Be the first to review this product! Submit a review

|

(26 Publications)

Anti-CD44 antibody [Hermes-3] (ab254530) is a mouse monoclonal antibody detecting CD44 in Western Blot, IP, IHC-P, ICC/IF, ELISA. Suitable for Human.

- KO validated for confirmed specificity

View Alternative Names

CD44, LHR, MDU2, MDU3, MIC4, CD44 antigen, CDw44, Epican, Extracellular matrix receptor III, GP90 lymphocyte homing/adhesion receptor, HUTCH-I, Heparan sulfate proteoglycan, Hermes antigen, Hyaluronate receptor, Phagocytic glycoprotein 1, Phagocytic glycoprotein I, ECMR-III, PGP-1, PGP-I

8 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [Hermes-3] (AB254530)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [Hermes-3] (AB254530)

Immunohistochemical analysis of paraffin-embedded human skin tissue labeling CD44 with ab254530 at 0.107μg/ml, followed by ready to use secondary. Membranous staining on human skin is observed. The section was incubated with ab254530 for 5 mins at RT. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, followed by ready to use secondary.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.

Immunocytochemistry/ Immunofluorescence - Anti-CD44 antibody [Hermes-3] (AB254530)
  • ICC/IF

Collaborator

Immunocytochemistry/ Immunofluorescence - Anti-CD44 antibody [Hermes-3] (AB254530)

ab254530 was shown to react with CD44 in wild-type HAP1 cells in Immunocytochemistry with loss of signal observed in a CD44 knockout cell line. Wild-type and knockout cells were mixed and pelleted at a 1 : 1 ratio on coverslips. The cells were fixed with 4% paraformaldehyde (15 min) then permeabilized with 0.1% Triton X-100 (10min) and then blocked. The cells were then incubated with ab254530 at 1/500 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a secondary antibody to (Alexa Fluor® 555) at 0.5 μg/ml. Acquisition of the green (wild-type), red (antibody staining) and far-red (knockout) channels was performed. Representative grayscale images of the red channel are shown. Wild-type and knockout cells are outlined with yellow and magenta dashed line, respectively. Schematic representation of the mosaic strategy used is shown on the bottom-right panel. Image was acquired with a Zeiss(LSM-880). These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

Immunocytochemistry/ Immunofluorescence - Anti-CD44 antibody [Hermes-3] (AB254530)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-CD44 antibody [Hermes-3] (AB254530)

ab254530 staining CD44 in wild-type HeLa cells (top panel) and CD44 knockout HeLa cells (ab262515)(bottom panel). The cells were fixed with 100% methanol (5 min) then permeabilized with 0.1% Tween for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab254530 at 0.4μg/ml concentration and ab6046 (Rabbit polyclonal to beta Tubulin) at 1/1000 dilution overnight at 4°C followed by a further incubation at room temperature for 1h with a goat secondary antibody to mouse IgG (Alexa Fluor® 488) (ab150117) at 2 μg/ml (shown in green) and a goat secondary antibody to rabbit IgG (Alexa Fluor® 594) (ab150080) at 2 μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems TCS SP8).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [Hermes-3] (AB254530)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD44 antibody [Hermes-3] (AB254530)

Immunohistochemical analysis of paraffin-embedded human bladder carcinoma tissue labeling CD44 with ab254530 at 0.107μg/ml, followed by ready to use secondary. Membranous staining on human bladder carcinoma is observed. The section was incubated with ab254530 for 5 mins at RT. The immunostaining staining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, followed by ready to use secondary.

Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.

Immunoprecipitation - Anti-CD44 antibody [Hermes-3] (AB254530)
  • IP

Collaborator

Immunoprecipitation - Anti-CD44 antibody [Hermes-3] (AB254530)

Immunoprecipitation of CD44 in HAP1 cells. Lysates were prepared and immunoprecipitation was performed using 1.0 μg of ab254530 pre-coupled to prot.G-Sepharose beads. Samples were washed and processed for western blot with ab189524 at 1/2000. SM=10% starting material; UB=10% unbound fraction; IP=immunoprecipitate. These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Immunoprecipitation - Anti-CD44 antibody [Hermes-3] (ab254530)

Predicted band size: 81 kDa

false

ELISA - Anti-CD44 antibody [Hermes-3] (AB254530)
  • ELISA

Supplier Data

ELISA - Anti-CD44 antibody [Hermes-3] (AB254530)

ELISA - Anti-CD44 antibody [Hermes-3] (ab254530).

Antigen : Human CD44.

ab254530 used at 100-1000μg/ml.

Secondary is an Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Mouse IgG (H+L) used at a 1/1000 dilution.

Western blot - Anti-CD44 antibody [Hermes-3] (AB254530)
  • WB

Supplier Data

Western blot - Anti-CD44 antibody [Hermes-3] (AB254530)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-CD44 antibody [Hermes-3] (ab254530) at 0.536 µg/mL

Lane 1:

A549 (human lung carcinoma epithelial cell) whole cell lysate at 20 µg

Lane 2:

HeLa (human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Peroxidase-Conjugated Goat anti-Mouse IgG (H+L) at 1/10000 dilution

Predicted band size: 81 kDa

false

Exposure time: 1s

Western blot - Anti-CD44 antibody [Hermes-3] (AB254530)
  • WB

Collaborator

Western blot - Anti-CD44 antibody [Hermes-3] (AB254530)

ab254530 was shown to react with CD44 in wild-type HAP1 cells in Western blot with loss of signal observed in a CD44 knockout cell line. Wild-type HAP1 and CD44 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab254530 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with goat anti-mouse HRP secondary antibodies at 0.3ug/mL before imaging. These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.

All lanes:

Western blot - Anti-CD44 antibody [Hermes-3] (ab254530) at 1/1000 dilution

Lane 1:

Wild-type HAP1 cell lysate at 20 µg

Lane 2:

CD44 knockout HAP1 cell lysate at 20 µg

Predicted band size: 81 kDa

false

  • Carrier free

    Anti-CD44 antibody [Hermes-3] - BSA and Azide free

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

Hermes-3

Isotype

IgG2a

Carrier free

No

Reacts with

Human

Applications

ICC/IF, IHC-P, WB, IP, ELISA

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.536 µg/mL", "WB-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "0.107 µg/mL", "IHCP-species-notes": "<p></p> Perform heat-mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol." }, "Recombinant fragment - Human": { "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "", "ELISA-species-checked": "testedAndGuaranteed", "ELISA-species-dilution-info": "1/100 - 1/1000", "ELISA-species-notes": "<p>10-1000ng/ml</p>", "WB-species-checked": "notRecommended", "WB-species-dilution-info": "", "WB-species-notes": "", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "" } } }

Product details

What is this antibody validated in?
Anti-CD44 antibody [Hermes-3] (ab254530) is a mouse recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Human samples.

What is the molecular weight of CD44?
Anti-CD44 [Hermes-3] (ab254530) specifically detects a band for CD44 (UniProt: P16070) at a molecular weight of 81kDa.

Specificity confirmed
The specificity of Anti-CD44 antibody [Hermes-3] (ab254530) has been confirmed by Immunocytochemistry/ Immunofluorescence testing in CD44 Knockout HeLa cell line, ab262515.

Other related products
We have a range of other formats of antibody clone [Hermes-3] also available for your convenience: ab254530, Carrier free - ab255946

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Want a custom formulation?
This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Cell-surface receptor that plays a role in cell-cell interactions, cell adhesion and migration, helping them to sense and respond to changes in the tissue microenvironment (PubMed : 16541107, PubMed : 19703720, PubMed : 22726066). Participates thereby in a wide variety of cellular functions including the activation, recirculation and homing of T-lymphocytes, hematopoiesis, inflammation and response to bacterial infection (PubMed : 7528188). Engages, through its ectodomain, extracellular matrix components such as hyaluronan/HA, collagen, growth factors, cytokines or proteases and serves as a platform for signal transduction by assembling, via its cytoplasmic domain, protein complexes containing receptor kinases and membrane proteases (PubMed : 18757307, PubMed : 23589287). Such effectors include PKN2, the RhoGTPases RAC1 and RHOA, Rho-kinases and phospholipase C that coordinate signaling pathways promoting calcium mobilization and actin-mediated cytoskeleton reorganization essential for cell migration and adhesion (PubMed : 15123640). Upon interaction with LGALS9 ligand, activates downstream signaling components including LCK, ERK and MAPK to promotes NK cell activation (PubMed : 37006235).. (Microbial infection) Promotes foot-and-mouth disease virus internalization via macropinocytosis.
See full target information CD44

Publications (26)

Recent publications for all applications. Explore the full list and refine your search

Acta neuropathologica communications 13:188 PubMed40898372

2025

Optineurin deficiency disrupts phosphorylated tau proteostasis and clusterin expression in human neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Zachary M Augur,Garrett M Fogo,Mason R Arbery,Andrew M Stern,Courtney R Benoit,Yi-Chen Hsieh,Tracy L Young-Pearse

World journal of surgical oncology 23:148 PubMed40259397

2025

Ganoderic acid a potentiates cisplatin's cytotoxicity on gallbladder cancer cells by promoting DNA damage and inhibiting cell stemness.

Applications

Unspecified application

Species

Unspecified reactive species

Gan Zhang,Haoming Lan,Jie Wu,Xianfeng Sheng,Linsheng Huang,Meng Zhou,Jun Hu

ACS nano 19:13685-13704 PubMed40176316

2025

Peptide-Modified Lipid Nanoparticles Boost the Antitumor Efficacy of RNA Therapeutics.

Applications

Unspecified application

Species

Unspecified reactive species

Gangyin Zhao,Ye Zeng,Wanli Cheng,Sofia Karkampouna,Panagiota Papadopoulou,Bochuan Hu,Shuya Zang,Emma Wezenberg,Gabriel Forn-Cuní,Bruno Lopes-Bastos,Marianna Kruithof-de Julio,Alexander Kros,B Ewa Snaar-Jagalska

Cell death & disease 16:178 PubMed40097394

2025

TFE3 and HIF1α regulates the expression of SHMT2 isoforms via alternative promoter utilization in ovarian cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Si-Qi Wang,Ning Liu,Qi Zhang,Bai-Qiang Li,Fu-Ying Zhao,Chao Li,Hua-Qin Wang,Chuan Liu

World journal of clinical oncology 16:97296 PubMed39995553

2025

Targeting STAT3 with SH-4-54 suppresses stemness and chemoresistance in cancer stem-like cells derived from colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Xu-Fan Zhang,Qian Chen,Qin Jiang,Qiong-Ying Hu

Materials today. Bio 31:101501 PubMed39944529

2025

Targeted inhibition of ferroptosis in bone marrow mesenchymal stem cells by engineered exosomes alleviates bone loss in smoking-related osteoporosis.

Applications

Unspecified application

Species

Unspecified reactive species

Yao Wang,Lin Sun,Zhenglin Dong,Tianyu Zhang,Leining Wang,Yihui Cao,Hui Xu,Chenglei Liu,Bo Chen

Clinical and translational medicine 15:e70175 PubMed39934971

2025

Immune profiling of the macroenvironment in colorectal cancer unveils systemic dysfunction and plasticity of immune cells.

Applications

Unspecified application

Species

Unspecified reactive species

Haoxian Ke,Peisi Li,Zhihao Li,Xian Zeng,Chi Zhang,Shuzhen Luo,Xiaofang Chen,Xinlan Zhou,Shichen Dong,Shaopeng Chen,Junfeng Huang,Ming Yuan,Runfeng Yu,Shubiao Ye,Tuo Hu,Zhonghui Tang,Dongbin Liu,Kui Wu,Xianrui Wu,Ping Lan

Frontiers in immunology 15:1446453 PubMed39691723

2024

Identification of macrophages as an immune suppressor in hepatocellular carcinoma using single-cell and bulk transcriptomics.

Applications

Unspecified application

Species

Unspecified reactive species

Han Jin,Woonghee Kim,Meng Yuan,Xiangyu Li,Hong Yang,Mengzhen Li,Mengnan Shi,Hasan Turkez,Mathias Uhlen,Cheng Zhang,Adil Mardinoglu

International journal of molecular sciences 25: PubMed39684426

2024

Machine Learning Integration with Single-Cell Transcriptome Sequencing Datasets Reveals the Impact of Tumor-Associated Neutrophils on the Immune Microenvironment and Immunotherapy Outcomes in Gastric Cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jingcheng Zhang,Mingsi Zhang,Jiaheng Lou,Linyue Wu,Shuo Zhang,Xiaojuan Liu,Yani Ke,Sicheng Zhao,Zhiyuan Song,Xing Bai,Yan Cai,Tao Jiang,Guangji Zhang

Animals : an open access journal from MDPI 14: PubMed39682386

2024

Curcumin Inhibits Oxidative Stress and Apoptosis Induced by HO in Bovine Adipose-Derived Stem Cells (bADSCs).

Applications

Unspecified application

Species

Unspecified reactive species

Enhui Jiang,Xuanbo Chen,Yi Bi,Chuanying Pan,Xiangchen Li,Xianyong Lan
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com